American Century Companies’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
OFM
LCM
DFO
American Century Companies's NUVB Position: Q2 2026 in Review
American Century Companies increased its Nuvation Bio (NUVB) stake by 55% in Q2 2026, buying an estimated $7.83M and bringing the position to 4,499,643 shares worth $25.6M. The position accounts for 0.01% of the portfolio, ranked #1171.
American Century Companies first reported a position in NUVB in Q2 2022 and has held it in 16 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.
- American Century Companies held 4,499,643 shares of Nuvation Bio worth $25.6M as of Q2 2026.
- American Century Companies bought 1,602,565 Nuvation Bio shares in Q2 2026, an estimated $7.83M.
- Nuvation Bio made up 0.01% of American Century Companies's portfolio in Q2 2026, its #1171 holding.
- American Century Companies first reported a position in Nuvation Bio in Q2 2022 and has held it in 16 quarters since.
- 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.